Canada’s first JDRF Centre of Excellence in Type 1 diabetes research, science and technology standing committee members announced, Ottawa invests in pandemic research and vaccine confidence projects, and more.
Topic: COVID variants
New COVID-19 portal aims to nationalize genomic data sharing
Canada is poised to launch a national portal that will provide a near real-time snapshot of the evolving COVID-19 pandemic across Canada, including the detection and spread of variants of concern. It will also establish the national data infrastructure Canada needs to track future pandemics.
Calgary vaccine developer reaches deal with Manitoba government after hearing no response from Ottawa
Providence Therapeutics, a Calgary biotechnology company in human trials with its COVID-19 vaccine, struck a supply deal with the Government of Manitoba after sending the federal government a proposal and receiving no response. In a video, Providence founder and CEO Brad Sorenson criticized Ottawa’s “apathetic response” as “unacceptable” and he implored the government to take initiative to establish a secure domestic vaccine supply.
Applied PeR$pectives
Building with CCNB-INNOV… Relationships that go a Long Way! CCNB-INNOV, the applied research and development arm of CCNB has adapted its range of services to better meet the unique needs of the regional shipbuilding industry.
 |
Applied PeR$pectives is a new monthly blog dedicated to highlighting the innovative work being done in the college and institute community. |
|---|
Fast Policy Facts
 |
December 12, 2018: Requiem for a National Network Program
|
|---|
Research Money on Twitter
Loading tweets...